At Best, FDA Will Carry Out Only Half Of Domestic Surveillance Inspections In FY 2021, Report Says
Agency vows to create Inspectional Affairs Council, modernize its regulatory oversight approach
Executive Summary
A 5 May report from the US FDA says that even under the most favorable COVID-19 conditions the agency’s inspections of makers of medical and tobacco products will likely be cut in half this fiscal year. The FDA also announced it will launch an agency-wide Inspectional Affairs Council to “plan and coordinate inspectional activities.”